Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001191072-10-000002
Filing Date
2010-01-08
Accepted
2010-01-08 16:36:55
Documents
1
Period of Report
2010-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 17766
  Complete submission text file 0001191072-10-000002.txt   19460
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
WILSON LINDA S (Reporting) CIK: 0001191072 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 10518022